Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hepatitis b drug shows early promise in small trial
Disease control CompletedThis early-stage study tested a new medicine called HH-006 in 36 adults with chronic hepatitis B who had not been treated before. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo as a shot once a week…
Phase: PHASE1 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New antibody HH-101 tested for safety in advanced cancer patients
Disease control CompletedThis early-phase study tested a new antibody called HH-101 in 12 adults with advanced solid tumors that had not responded to other treatments. The main goal was to check if the drug is safe and to find any side effects. Researchers also looked at how the drug moves through the bo…
Phase: PHASE1 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New antibody shows promise against rare liver infection
Disease control CompletedThis study tested an experimental drug called HH-003 in 101 adults with chronic hepatitis delta, a serious liver infection. The drug is an antibody that targets the hepatitis B virus, which is needed for hepatitis delta to survive. The goal was to see if the treatment could lower…
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC